Phase II Randomized Placebo-Controlled Trial of Cisplatin With or Without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer, With or Without Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Veliparib (Primary) ; Cisplatin
- Indications Breast cancer; Male breast cancer
- Focus Therapeutic Use
- 11 Dec 2017 Planned number of patients changed from 235 to 333.
- 10 Jun 2017 Biomarkers information updated
- 11 Jul 2016 Status changed from not yet recruiting to recruiting.